DALLAS, TX / ACCESSWIRE / September 14, 2017 / North American Cannabis Holdings, Inc. (OTC PINK: USMJ) and Puration, Inc. (OTC PINK: PURA) today announced adding a new FAQ page to the consolidated American Cannabis Conglomerated (“ACI”) website launched earlier this week. ACI recently acquired the controlling shareholder interest in both USMJ and PURA with plans to acquire shareholder interests in additional cannabis industry entrepreneurial companies. The FAQ section addresses several common questions received in emails and voicemails to include inquiries regarding the PURA common stock distributed in a dividend distribution to USMJ shareholders last December (2016). The new FAQ section also includes replies to questions regarding the availability of EVERx CBD Infused Sports water and questions about the combined companies’ new communication plan. Look for the FAQ section to be updated regularly. View the new FAQ section and the link below:
ACI FAQ PAGE FOR USMJ AND PURA
Review Website For Important Updates and Changes
The new website includes important updates and details on organizational and strategic changes. The reorganization of operations under ACI is already underway. USMJ and PURA are already adopting new go-to-market strategies and additional operational and marketing changes are anticipated soon. The website includes information regarding recent, pending and anticipated strategic and operational changes.
Learn more about ACI, USMJ and PURA by visiting: aciconglomerated.com
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
ACI, USMJ and PURA contact info to include email, phone and address:
SOURCE: North American Cannabis Holdings, Inc.